Neurosurgery in a patient on dual antiplatelet therapy. Case report and the review of the literature

Close metadata

Introduction. A neurosurgical intervention in a patient on dual antiplatelet therapy is a serious challenge for both the neurosurgeon and anesthesiologist. Material and methods. The article describes a clinical case of a successful urgent neurosurgical intervention (ventriculoperitoneostomy for obstructive hydrocephalus caused by a large meningioma of the posterior surface of the petrous pyramid) in a patient on dual antiplatelet therapy (DAT) due to a recently placed coronary stent. Conclusion. Given a high risk of coronary stent thrombosis, the surgery was performed in the presence of ongoing DAT. There were no intracranial hemorrhagic complications, but subcutaneous hemorrhagic complications developed. The article discusses the features of managing similar patients whose number is growing.

Keywords:

neurosurgical intervention

skull base tumors

coronary stent

dual antiplatelet therapy

neurosurgical intervention

skull base tumors

coronary stent

dual antiplatelet therapy

Authors:

Lubnin A.Yu.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia, N.N. Burdenko Research Institute of Neurosurgery, Moscow, Russia, Department of Obstetrics and Gynecology, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia

RSCI AuthorID: 370609
Scopus AuthorID: 57192157123
ORCID: 0000-0003-2595-5877

Karnaukhov V.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Moshkin A.V.

NII neĭrokhirurgii im. N.N. Burdenko RAMN, Moskva

ORCID: 0000-0002-9965-4578

Rylova A.V.

Burdenko Neurosurgical Institute, Moscow, Russia

Shimanskiĭ V.N.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

List of references:

Di Lorenzo E, Sauro R, Varrichio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca M, Stanco G, Rosato G, de Luca G. Long-term outcome of drug-eluting stents compared with bare metal stent in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent in primary angioplasty (PASEO) Randomized Trial. Circulation. 2009;120:11:964-972. doi: 10.1161/CIRCULATIONAHA.108.830372
Fischman DL, Leon MB, Baim DS Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501. doi: 10.1056/nejm199408253310802
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P. A. comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495. doi: 10.1056/nejm199408253310801
Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JJ, Chauhan MS, Rodriguez O, Kuntz RE. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001;103:1967-1971. doi:10.1016/s1062-1458(01)00403-2
Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-1029. doi: 10.1056/nejmoa067731
Rylova A, Lubnin A. Coronary artery stents and neurosurgery: choosing the lesser of two evils. Anesteziologija i reanimatologija. 2013;4:71-76. (In Russ.).
Roth E, Purnell C, Shabalov O, Moguillansky D, Hernandez CA, Elnicki M. Perioperative management of patient with recently placed drug-eluting stents requiring urgent spinal surgery. J Gen Intern Med. 2012;27:1080-1083. doi: 10.1007/s11606-012-1995-7/
Than KD, Rohatgi P, Wilson TJ, Gregory Thompson B. Perioperative management of a neurosurgical patient requiring antiplatelet therapy. J Clin Neurosci. 2012;19:1316-1320.
Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011;305:1769-1776. doi:10.1001/jama.2011.551/
Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Use of drug-eluted stents as a function of predicted benefit clinical and economic implications of current practice. Arch Intern Med. 2012;172:1145-1152. doi: 10.1001/archinternmed.2012.3093
Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol. 2007;50:463-470. doi:10.1016/j.jacc.2007.06.002
Iakovoy I, Schmidt T, Bonizzjni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130. doi: 10.1001/jama.293.17.2126
Karillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier B, Commeau P, Cribier A, Eiferman C, Grollier G, Guerin Y, Henry M, Lefevre T, Livarek B, Louvard Y, Marco J, Makowski S, Monassier JP, Pernes JM, Rioux P, Spaulding C, Zemour G. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French multicenter registry. Circulation. 1996;94:1519-1527. doi: 10.1161/01.cir.94.7.1519
Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluted stents with bare-metal stents. N Engl J Med. 2007;356:1030-1039.doi: 10.1056/nejmoa067484
Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997;29:6-12. doi: 10.1016/s0735-1097(96)00452-4
Ong A, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW. Thirty-day incidence and six-mount clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947-953. doi: 10.1016/j.accreview.2005.06.044
Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS, Holmes DR, Berger PB. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol. 2002;40:1567-1572. doi: 10.1016/s0735-1097(02)02374-4
Akhavan-Sigari R, Rohde V, Abili M. Continuation of medically necessary platelet aggregation inhibitors - acetylsalicylic acid and clopidogrel - during surgery for spinal degenerative disorders: Results in 100 patients. Surg Neurol Int. 2014;5(Suppl 7):376-379. doi: 10.4103/2152-7806.139675
Rouine-Rapp K, McDermott MW. Perioperative management of a neurosurgical patient with a meningeoma and recent coronary artery stent. J Clin Anesth. 2013;25:228-231. doi: 10.1016/j.jclinane.2012.11.007
Sung JH, Hong JT, Son BC, Lee SW. Clopidogrel-induced spontaneous spinal epidural hematoma. J Korean Med Sci. 2007;22:577-579. doi: 10.3346/jkms.2007.22.3.577
Bhat KD, Kapoor S, Watali YZ, Sharma JR. Spontaneous epidural hematoma of spine associated with clopidogrel: A case study and review of the literature. Asian J Neurosurg. 2015;10:54-58. doi: 10.4103/1793-5482.151521
Lim SH, Hong BY, Cho YR, Kim HS, Lee JI, Kim HW, Ko YJ. Relapsed spontaneous spinal epidural hematoma associated with aspirin and clopidogrel. Neurol Sci. 2011;32:687-689. doi: 10.10072-011-0508-5
Yang S, Zhang X, Jin Y. Spontaneous resolution of nontraumatic chronic subdural hematoma associated with anti-aggregation therapy. J Craniofac Surg. 2014;25:363-365. doi: 10.1097/SCS.0000000000000814
Pottegard A, Garcia Rodriguez LA, Poulsen FR, Hallas J, Gaist D. Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark. Thromb Haemost. 2015;114:753-758. doi: 10.1160/TH15-04-0316
Akkerhuis KM, Deckers JW, Lincoff AM, Tcheng JE, Boersma E, Anderson K, Balog C, Califf RM, Topol EJ, Simoons ML. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA. 2001;286:78-82. doi: 10.1001/jama.286.1.78
Quereshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including Abciximab. Stroke. 2002;33:1916-1919. doi: 10.1161/01.str.0000019423.08947.43
Yhoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ. Aspirin in Alzheimer’s disease increased risk of intracerebral hemorrhage: Cause for concern? Stroke. 2010;41:2690-2692. doi:10.1161/strokeaha.109.576975
ESC/ESA 2014 Guidelines on non-cardiac surgery: cardiovascular assessment and management. The joint Task Force on non cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anesthesiology (ESA). Eur Geart J. 2014;35:2383-2431. doi: 10.1093/eurheartj/ehu282
Zabolotskih I, Kirov M, Bozhkova S, Bulanov A, Vorobieva N, Grigoriev E, Gritsan A, Kurapeev I, Lebedinskiy K, Lomivorotov V, Ovechkin A, Potievskaya V, Sin’kov S, Subbotin V, Shulutko E, Lubnin A. Perioperative management of patients receiving long-term antithrombotic therapy. Clinical guidelines. Anesteziologija i reanimatologija. 2014;4:4-14. (In Russ.).
Ross IB, Dhillon GS. Ventriculostomy-related cerebral hemorrhage after endovascular aneurysm treatment. Am J Neuroradiol. 2003;24:1528-1531.
Misaki K, Uchiyama N, Hayashi Y, Hamada J. Intracerebral hemorrhage secondary to ventriculoperitoneal shunt insertion. Four case report. Neurol Med Chir. 2010;50:76-79. doi: 10.2176/nmc.50.76/
Birkeland P, Lauritsen J, Poulsen FR. Aspirin is associated with an increased risk of subdural hemathoma in normal-pressure hydrocephalus patients following shunt implantation. J Neurosurg. 2015;123:423-426. doi: 10.3171/2014.11.JNS14804
Kung DK, Policeni BA, Capuano AW, Rossen JD, Jabbour PM, Torner JC, Howard MA, Hasan D. Risk of ventriculostomy-related hemorrhage in patients with acutely ruptured aneurysms treated using stent-assisted coiling. J Neurosurg. 2011;114:1021-1027. doi: 10.3171/2010.9.JNS10445
Mahaney KB, Chalouhi N, Vilijoen S, Smietana J, Kung DK, Jabbour P, Bulsara KR, Howard M, Hasan DM. Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurismal subarachnoid hemorrhage patients on dual antiplatelet therapy. J Neurosurg. 2013;119:937-942. doi: 10.3171/2013.5.JNS122494
Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and noncardiac surgery - a prospective outcome study. Br J Anaesth. 2006;96:683-693. doi: 10.1097/00000542-200102000-00035/
Yakovlev S, Arustamyan S, Dorokhov P, Bocharov A, Bukharin E, Arkhangel'skaya Y, Aref'eva I. Endovascular treatment of large and giant intracranial aneurysms using flow-diverting stents. Voprosy neirokhirurgii imeni NN Burdenko. 2015;19-27. (In Russ.). doi: 10.17116/neiro201579419-27 doi: 10.17116/neiro201579419-27
Kass-Hout T, Alderazi YJ, Amuluru K, Jin P, Ayala C, Prestigiacomo C, Gandhi CD. Neurointerventional stenting and antiplatelet function testing: To do or not to do? Intervent Neurol. 2014;3:184-189. doi: 10.1159/000431261/
Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME. Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: A single-center experience. Am J Neuroradiol. 2008;29:1389-1394. doi: 10.3174/ajnr.A1070
Fifi JT, Brockington JT, Narang J, Leesch W, Ewing SL, Bennet H, Berenstein A, Chong J. Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. Am J Neuroradiol. 2013;34:716-720. doi: 10.3174/ajnr.A3405.
Rho GJ, Shin WR, Kong TS, Kim MS, Lee CJ, Lee BH. Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease. J Korean Neurosurg Soc. 2011;50:40-44. doi: 10.3340/jkns.2011.50.1.40
Ryu DS, Hong CK, Sim YS, Kim CH, Jung JY, Joo JY. Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointervention. J Korean Neurosurg Soc. 2010;48:319-324. doi: 10.3340/jrns.2010.48.4.319
Kim B, Kim K, Jeon P, Kim S, Kim H, Byun H, Cha J, Hong S, Jo K. Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. Am J Neuroradiol. 2014;35:1786-1792. doi: 10.3174/ajnr.A3955
Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J. 2006;27:647-654. doi: 10.1093/eurheartj/ehi684
Kono K, Shintani A, Yoshimura R, Okada H, Tanaka Y, Fujimoto T, Tomura N, Terada T. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms. Acta Neurochir. 2013;155:1549-1557. doi: 10.1007/s00701-013-1771-4.
Hwang G, Huh W, Lee JS, Villavicencio JB, Villamor RBJr, Ahn SY, Kim J, Chang JY, Park SJ, Park NM, Jeong EA, Kwon OK. Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysms: A randomized clinical trial. JAMA Neurol. 2015;72:764-772. doi: 10.1001/jamaneurol.2015.0654
Yang H, Li Y, Jiang Y, Lv X. Thromboelastography for monitoring platelet function in unruptured intracranial aneurysm patients undergoing stent placement. Interv Neuroradiol. 2015;21:61-68. doi: 10.15274/INR-2014-10094
Favolaro EJ, Bonar R. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update. Semin Thromb Hemost. 2014;40:239-253. doi: 10.1055/s-0034-1365844
Yamaguchi Y, Abe T, Sato Y, Matsubara Y, Moriki T, Murata M. Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: a systematic review and meta-analysis. Platelets. 2013;24:352-361. doi: 10.3109/09537104.2012.700969
Sedat J, Chau Y, Mondot L, Chemla R, Lonjon M, Padovani B. Is eptifibatide a safe and effective rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization? Single-center experience in 42 cases and review of the literature. Neuroradiol. 2014;56:145-153. doi: 10.1007/s00234-013-1301-3
Picket AM, Taylor DA, Ackman ML. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature. Pharmacother. 2010;30:127-133. doi: 10.1592/phco/30.4.420
Reaume KT, Regal RE, Dorsch MP. Indications for dual antiplatelet theraphy with aspirin and clopidogrel: evidence-based recommendations for use. Ann Pharmacother. 2008;42:550-557. doi: 10.1345/aph.1K433
Kalieadan A, Siu H, Fischman DL, Ruggiero NJ2nd, Jasti B, Walinsky P, Ogilby JD, Savage MP. «Very» very late stent thrombosis: acute myocardial infarction from drug-eluting stent thrombosis more than 5 years after implantation. J Invasive Cardiol. 2014;26:413-416. doi: 10.1016/j.jcin.2014.01.009
Murray AT, Sederberg JH. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet theraphy. Semin Cardiothorac Vasc Anesth. 2011;15:40-43. doi: 10.1177/1089253211411103

Close metadata